EFFECTS OF MR-GUIDED AND ULTRASOUND-GUIDED FOCUSED ULTRASOUND TREATMENT FOR ADENOMYOSIS ON OVARIAN RESERVE ASSESSED BY ANTI-MÜLLERIAN HORMONE LEVELS: A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5360Keywords:
Adenomyosis, MRgFUS, USgHIFU, Anti-Müllerian Hormone, HIFUAbstract
Aim: This narrative review evaluates the current evidence on the impact of high-intensity focused ultrasound (HIFU), including MR-guided (MRgFUS) and ultrasound-guided (USgHIFU) techniques, on ovarian reserve in women treated for adenomyosis, with particular emphasis on anti-Müllerian hormone (AMH) level.
Methods: narrative review included evidence from prospective and retrospective studies, randomized trials, and original research in patients with adenomyosis, identified through searches of PubMed/MEDLINE, Embase, Web of Science, and Google Scholar.
Results: available studies consistently demonstrate that this treatment does not result in significant changes in AMH concentrations, irrespective of the method used, suggesting preservation of ovarian reserve.
Conclusion: In contrast to more invasive treatment options, such as uterine artery embolization or hysterectomy, HIFU acts locally, minimizing the risk of damage to ovarian tissue and vascular supply. This enables the preservation of fertility, which is particularly important for women desiring future childbearing. However, the available evidence is limited by small sample sizes, heterogeneous study populations, and short follow-up periods. Further large-scale, prospective studies with long-term follow-up are needed to confirm the sustained safety of HIFU and its impact on reproductive outcomes.
References
Bahutair, S. N., & Alhubaishi, L. Y. (2024). High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects. Women’s Health, 20, 17455057241295593. https://doi.org/10.1177/17455057241295593
Benagiano, G., Habiba, M., & Brosens, I. (2012). The pathophysiology of uterine adenomyosis: An update. Fertility and Sterility, 98(3), 572–579. https://doi.org/10.1016/j.fertnstert.2012.06.044
Cai, Y., Sun, Y., Xu, F., Wu, Y., Ren, C., Hao, X., Gao, B., & Cao, Q. (2023). Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis. Scientific Reports, 13(1), 9903. https://doi.org/10.1038/s41598-023-37096-y
Fan, T. Y., Zhang, L., Chen, W., Liu, Y., He, M., Huang, X., Orsi, F., & Wang, Z. (2012). Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis. European Journal of Radiology, 81(11), 3624–3630. https://doi.org/10.1016/j.ejrad.2011.05.036
Keserci, B., & Duc, N. M. (2018). Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: Retrospective multivariate analysis. International Journal of Hyperthermia, 35(1), 626–636. https://doi.org/10.1080/02656736.2018.1516301
Lee, J. S., Hong, G. Y., Lee, K. H., & Kim, T. E. (2017). Changes in anti-Müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid. BJOG: An International Journal of Obstetrics & Gynaecology, 124(Suppl. 3), 18–22. https://doi.org/10.1111/1471-0528.14739
Lee, J. S., Hong, G. Y., Lee, K. H., Song, J. H., & Kim, T. E. (2019). Safety and efficacy of ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroids and adenomyosis. Ultrasound in Medicine & Biology, 45(12), 3214–3221. https://doi.org/10.1016/j.fertnstert.2012.06.044
Leporace, M., Calabria, F. F., Siciliano, R., Capalbo, C., Filippiadis, D. K., & Iezzi, R. (2024). The thermal ablation with MRgFUS: From physics to oncological applications. Cancers, 17(1), 36. https://doi.org/10.3390/cancers17010036
Moolhuijsen, L. M. E., & Visser, J. A. (2020). Anti-Müllerian hormone and ovarian reserve: Update on assessing ovarian function. The Journal of Clinical Endocrinology & Metabolism, 105(11), 3361–3373. https://doi.org/10.1210/clinem/dgaa513
Otonkoski, S., Sainio, T., Mattila, S., Blanco Sequieros, R., Perheentupa, A., Komar, G., & Joronen, K. (2023). Magnetic resonance guided high intensity focused ultrasound for uterine fibroids and adenomyosis has no effect on ovarian reserve. International Journal of Hyperthermia, 40(1), 2154575. https://doi.org/10.1080/02656736.2022.2154575
Practice Committee of the American Society for Reproductive Medicine. (2020). Testing and interpreting measures of ovarian reserve: A committee opinion. Fertility and Sterility, 114(6), 1151–1157. https://doi.org/10.1016/j.fertnstert.2020.09.134
Santulli, P., Vannuccini, S., Bourdon, M., Chapron, C., & Petraglia, F. (2025). Adenomyosis: The missed disease. Reproductive BioMedicine Online, 50(4), 104837. https://doi.org/10.1016/j.rbmo.2025.104837
Schrager, S., Yogendran, L., Marquez, C. M., & Sadowski, E. A. (2022). Adenomyosis: Diagnosis and management. American Family Physician, 105(1), 33–38. https://pubmed.ncbi.nlm.nih.gov/35029928/
Wei, J., Wang, L., Tao, H., Wang, X., Zheng, F., He, P., Zhou, L., Fan, L., Chen, J., Zhong, H., Huang, W., Zeng, D., & Li, J. (2023). Comparison of pregnancy outcomes in infertile patients with different types of adenomyosis treated with high-intensity focused ultrasound. International Journal of Hyperthermia, 40(1), 2238140. https://doi.org/10.1080/02656736.2023.2238140
Yu, O., Schulze-Rath, R., Grafton, J., Hansen, K., Scholes, D., & Reed, S. D. (2020). Adenomyosis incidence, prevalence and treatment: United States population-based study 2006–2015. American Journal of Obstetrics and Gynecology, 223(1), 94.e1–94.e10. https://doi.org/10.1016/j.ajog.2020.01.016
Zhang, H., Li, C., Li, W., Xin, W., & Qin, T. (2024). Research advances in adenomyosis-related signaling pathways and promising targets. Biomolecules, 14(11), 1402. https://doi.org/10.3390/biom14111402
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Kornelia Julia Fimiarz, Kinga Łysak, Sonia Pawełkiewicz, Irmina Grygutis, Aleksandra Suchołbiak, Urszula Jarzęcka, Kaja Kozielec, Maja Kozielec
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
